Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Epilepsy, Complex Partial
Interventions
DRUG

Zonisamide

Trial Locations (35)

9

Odessa Medical University, Odesa

116

Semmelweis University Health Science Faculty, Budapest

2600

Vilnius University Hospital, Vilnius

3007

Kaunas Medical University Clinics, Kaunas

12205

Upstate Clinical Research Center, Albany

13419

Tallinn Children's Hospital, Tallinn

Tartu University Hospital, Tartu

14127

Dent Neurological Institute, Orchard Park

15601

Westmoreland Neurology Associates, Inc., Greensburg

21229

St. Agnes Health Care, Inc., Baltimore

24014

Blue Ridge Research Center, Roanoke

27103

Epilepsy Institute of North Carolina, Winston-Salem

30033

Neurology & Headache Specialist of Atlanta, LLC, Decatur

31002

Kharkov State Medical University, Kharkiv

31068

Institute of Neurology, Psychiatry, and Narcology of AMS Ukraine, Kharkiv

32308

AMO Corporation, Tallahassee

32405

Bay Neurological Institute, Panama City

32751

Neurology Associates, Maitland

33613

Florida Epilepsy & Seizure Disorder Center, PA, Tampa

33701

Suncoast Neuroscience Associates, Inc., St. Petersburg

35294

UAB Epilepsy Center, Birmingham

35476

Neurology Clinic, P.C., Northport

35801

North Alabama Neuroscience, Huntsville

40205

Louisville Neuroscience Research Center, Louisville

45219

River Hills Health Care, Cincinnati

53792

University of Wisconsin, Madison

62707

Southern Illinois University School of Medicine Dept. of Neurology, Springfield

63017

The Comprehensive Epilepsy Care Center, Chesterfield

78229

Neurology Clinic of San Antonio, San Antonio

91325

Northridge Neurological Center, Northridge

92037

Coordinated Clinical Research, San Diego

98405

Neurology & Neurosurgery Associates of Tacoma, Inc. P.S., Tacoma

254655

Epilepsy Center, Kiev

02914

CNS Research, INC, East Providence

H1145

National Institute of Neurosurgery Epilepsy Center, Budapest

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00056576 - Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy | Biotech Hunter | Biotech Hunter